Literature DB >> 10037290

Carbamazepine-induced sensorineural hearing loss.

M de la Cruz1, M Bance.   

Abstract

Carbamazepine is a commonly prescribed anticonvulsant medication that affects various levels of the nervous system. We report a case of temporary sensorineural hearing loss in a patient after overdosing with 36 g of carbamazepine. Six days after the overdose, the patient complained of bilateral hearing loss and tinnitus. Audiograms revealed a 30- to 40-dB sensorineural hearing loss bilaterally. Another audiogram 2 weeks later showed a complete recovery in both ears accompanied by a clinical resolution in audiovestibular symptoms. Carbamazepine is used to treat partial and generalized seizures, trigeminal neuralgia, and bipolar illness. Adverse effects are not common but most frequently include dizziness, drowziness, nausea, and skin rashes; rare complications are agranulocytosis, bradycardia, and heart block. Documented hearing loss as a side effect of carbamazepine has not been reported, to our knowledge.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037290     DOI: 10.1001/archotol.125.2.225

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

Review 1.  The inner ear and the neurologist.

Authors:  Charlotte Agrup; Michael Gleeson; Peter Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02       Impact factor: 10.154

2.  Sensory Deprivation and Psychiatric Disorders: Association, Assessment and Management Strategies.

Authors:  Swapnajeet Sahoo; Chandrima Naskar; Ajaypal Singh; Rika Rijal; Aseem Mehra; Sandeep Grover
Journal:  Indian J Psychol Med       Date:  2021-09-21

3.  Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder.

Authors:  Sumit Kumar Gupta; Bansal Shwetank
Journal:  Indian J Pharmacol       Date:  2014 Jul-Aug       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.